fluorouracil has been researched along with Enteropathy, Exudative in 2 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kondo, M | 2 |
Nakanishi, K | 2 |
Bamba, T | 2 |
Hosokawa, K | 2 |
Masuda, M | 1 |
Tanaka, H | 1 |
2 other studies available for fluorouracil and Enteropathy, Exudative
Article | Year |
---|---|
Experimental protein-losing gastroenteropathy: role of tissue plasminogen activator.
Topics: Animals; Fibrinolysin; Fibrinolysis; Fluorouracil; Intestinal Mucosa; Ligation; Male; Povidone; Prot | 1976 |
[Local fibrinolytic activity of the digestive tract mucosa--II. Protein-losing gastroenteropathy].
Topics: Animals; Female; Fibrinolysis; Fluorouracil; Gastric Mucosa; Intestinal Mucosa; Male; Mice; Protein- | 1975 |